Subscribe
Sign in
Home
Notes
Archive
About
From EBITDA to Exit
How Your GTM Actually Moves the Needle of the EBITDA multiple.
READ THE LATEST
Latest
Top
Discussions
The Colonoscopy
A Structured Approach to Pipeline Accountability Without Anesthesia.
Mar 4
•
Sal Mikel
3
Your Win-Rate Might Be Fooling You
It’s very likely that your win-rate—and a few other comforting ratios—are lying to your face.
Oct 7, 2025
•
Sal Mikel
2
Google Ads: The World’s Most Expensive Casino
House always wins — unless you fix your strategy, execution, and attribution.
Aug 22, 2025
•
Sal Mikel
3
Asking for a Friend: Should I Be Leading This Team?
Are you a wizard pretending to be a builder?
Jul 22, 2025
•
Sal Mikel
1
1
The Tight Correlation Between Zodiac Signs and Sales Forecasting
Yes, Zodiac-sign forecasting is more precise than your current method.
Jul 3, 2025
•
Sal Mikel
2
1
CRMs: The Colonoscopy of the GTM World
Deeply invasive, widely dreaded. Yet, vital.
Jun 19, 2025
•
Sal Mikel
3
1
Sales Incentives: What Do You Need—Koalas or Sharks?
More Money, More Sales. Well… maybe.
Jun 11, 2025
•
Sal Mikel
2
See all
The Sales Calamity
Dissecting what breaks your go-to-market —and how to fix it.
Subscribe
Recommendations
The Jim Acosta Show
Jim Acosta
Pete Buttigieg's Substack
Pete Buttigieg
Granted
Adam Grant
The Borowitz Report
Andy Borowitz
Paul Krugman
Paul Krugman
Social Media
LinkedIn
Instagram
The Sales Calamity
Subscribe
About
Archive
Recommendations
Sitemap
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
